⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4189631 | 1.00 | — | — | |
| SCHEMBL678889 | 0.96 | — | — | |
| SCHEMBL4162255 | 0.96 | MGLL (0.30) | — | |
| SCHEMBL4178502 | 0.96 | MGLL (0.30) | — | |
| Hydrochloric Acid SCHEMBL7350676 | 0.93 | ALDH1A1 (0.30) | — | |
| Hydrochloric Acid SCHEMBL16212815 | 0.93 | ALDH1A1 (0.30) | — | |
| SCHEMBL2306907 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL29673103 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL27435759 | 0.89 | — | — | |
| SCHEMBL28564141 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 680 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024099337-A1 | THIADIAZOLYL DERIVATIVES, COMPOSITIONS, AND USES THEREOF | DANATLAS PHARMACEUTICALS CO., LTD. (CN) | 2024-05-16 | — | — | WO | claimed |
| WO-2024017354-A1 | METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOR | BEIGENE, LTD. (KY) | 2024-01-25 | — | — | WO | claimed |
| EP-3921320-A1 | IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | BeiGene, Ltd. (KY) | 2021-12-15 | — | — | EP | claimed |
| EP-3898639-A1 | OXOPYRIDO[1,2-A]PYRIMIDINE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | F. Hoffmann-La Roche AG (CH) | 2021-10-27 | — | — | EP | claimed |
| US-20210317141-A1 | OXOPYRIDO[1,2-A]PYRIMIDINE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2021-10-14 | — | — | US | claimed |
| US-20210253575-A1 | PYRROLIDINE AMINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE | HOFFMANN-LA ROCHE INC. (US) | 2021-08-19 | — | — | US | claimed |
| CN-113195503-A | Oxopyrido [1,2-A ] pyrimidine compounds for the treatment and prevention of bacterial infections | 豪夫迈·罗氏有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-113164418-A | Combination therapy | 米拉蒂治疗股份有限公司 | 2021-07-23 | — | — | CN | claimed |
| EP-3601282-B1 | NOVEL PYRIDO[2,3-B]INDOLE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | HOFFMANN LA ROCHE (CH) | 2021-07-21 | — | — | EP | claimed |
| EP-3847165-A1 | NOVEL PYRROLIDINE AMINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2021-07-14 | — | — | EP | claimed |
| EP-1370546-A2 | NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | Abbott Laboratories (US) | 2003-12-17 | — | — | EP | claimed |
| US-20030199478-A1 | 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors | ALLERGAN, INC. | 2003-10-23 | — | — | US | claimed |
| WO-2003027102-A1 | 3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS | ALLERGAN, INC. (US) | 2003-04-03 | — | — | WO | claimed |
| WO-2002079753-A2 | 2-AMINOBENZOXAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2002-10-10 | — | — | WO | claimed |
| WO-2002074758-A2 | NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | ABBOTT LABORATORIES (US) | 2002-09-26 | — | — | WO | claimed |
| EP-0160284-B1 | QUINO-BENOXAZINE ANTIBACTERIAL COMPOUNDS | ABBOTT LABORATORIES (US) | 1990-10-24 | — | — | EP | claimed |
| EP-0162333-B1 | QUINO-BENZOTHIAZINE ANTIBACTERIAL COMPOUNDS | ABBOTT LABORATORIES (US) | 1990-06-27 | — | — | EP | claimed |
| US-4607032-A | Quino-benoxazine antibacterial compounds | ABBOTT LABORATORIES (US) | 1986-08-19 | — | — | US | claimed |
| EP-0162333-A1 | Quino-benzothiazine antibacterial compounds | ABBOTT LABORATORIES (US) | 1985-11-27 | — | — | EP | claimed |
| EP-0160284-A1 | Quino-benoxazine antibacterial compounds | ABBOTT LABORATORIES (US) | 1985-11-06 | — | — | EP | claimed |